Literature DB >> 32250974

Glucose metabolism in Cushing's syndrome.

Anu Sharma1, Adrian Vella2.   

Abstract

PURPOSE OF REVIEW: Impairment of glucose metabolism is commonly encountered in Cushing's syndrome. It is the source of significant morbidity and mortality even after successful treatment of Cushing's. This review is to understand the recent advances in understanding the pathophysiology of diabetes mellitus from excess cortisol. RECENT
FINDINGS: In-vitro studies have led to significant advancement in understanding the molecular effects of cortisol on glucose metabolism. Some of these findings have been translated with human data. There is marked reduction in insulin action and glucose disposal with a concomitant, insufficient increase in insulin secretion. Cortisol has a varied effect on adipose tissue, with increased lipolysis in subcutaneous adipose tissue in the extremities, and increased lipogenesis in visceral and subcutaneous truncal adipose tissue.
SUMMARY: Cushing's syndrome results in marked impairment in insulin action and glucose disposal resulting in hyperglycemia. Further studies are required to understand the effect on incretin secretion and action, gastric emptying, and its varied effect on adipose tissue.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32250974      PMCID: PMC8130620          DOI: 10.1097/MED.0000000000000537

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  68 in total

1.  Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

Authors:  A Colao; R Pivonello; S Spiezia; A Faggiano; D Ferone; M Filippella; P Marzullo; G Cerbone; M Siciliani; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1999-08       Impact factor: 5.958

Review 2.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

3.  Diagnosis and complications of Cushing's disease: gender-related differences.

Authors:  Marialuisa Zilio; Mattia Barbot; Filippo Ceccato; Valentina Camozzi; Franca Bilora; Alessandra Casonato; Anna Chiara Frigo; Nora Albiger; Viviana Daidone; Linda Mazzai; Franco Mantero; Carla Scaroni
Journal:  Clin Endocrinol (Oxf)       Date:  2013-09-04       Impact factor: 3.478

Review 4.  Effects of glucocorticoids on carbohydrate metabolism.

Authors:  M McMahon; J Gerich; R Rizza
Journal:  Diabetes Metab Rev       Date:  1988-02

5.  Glucocorticoids suppress GLP-1 secretion: possible contribution to their diabetogenic effects.

Authors:  Camilla Kappe; Liselotte Fransson; Petra Wolbert; Henrik Ortsäter
Journal:  Clin Sci (Lond)       Date:  2015-04-08       Impact factor: 6.124

6.  The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements.

Authors:  Beth T Vander Kooi; Hiroshi Onuma; James K Oeser; Christina A Svitek; Shelley R Allen; Craig W Vander Kooi; Walter J Chazin; Richard M O'Brien
Journal:  Mol Endocrinol       Date:  2005-07-21

7.  Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes.

Authors:  Simmi Dube; Michael Q Slama; Ananda Basu; Robert A Rizza; Rita Basu
Journal:  J Clin Endocrinol Metab       Date:  2015-08-26       Impact factor: 5.958

8.  Glucose-Dependent Granule Docking Limits Insulin Secretion and Is Decreased in Human Type 2 Diabetes.

Authors:  Nikhil R Gandasi; Peng Yin; Muhmmad Omar-Hmeadi; Emilia Ottosson Laakso; Petter Vikman; Sebastian Barg
Journal:  Cell Metab       Date:  2018-02-06       Impact factor: 27.287

9.  11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.

Authors:  Stuart A Morgan; Mark Sherlock; Laura L Gathercole; Gareth G Lavery; Carol Lenaghan; Iwona J Bujalska; David Laber; Alice Yu; Gemma Convey; Rachel Mayers; Krisztina Hegyi; Jaswinder K Sethi; Paul M Stewart; David M Smith; Jeremy W Tomlinson
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

10.  Pancreatic alpha-cell dysfunction contributes to the disruption of glucose homeostasis and compensatory insulin hypersecretion in glucocorticoid-treated rats.

Authors:  Alex Rafacho; Luiz M Gonçalves-Neto; Junia C Santos-Silva; Paloma Alonso-Magdalena; Beatriz Merino; Sebastião R Taboga; Everardo M Carneiro; Antonio C Boschero; Angel Nadal; Ivan Quesada
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more
  3 in total

1.  Perioperative Management of a Patient With Cushing Disease.

Authors:  Elena V Varlamov; Greisa Vila; Maria Fleseriu
Journal:  J Endocr Soc       Date:  2022-01-28

2.  Meditative practices, stress and sleep among students studying complementary and integrative health: a cross-sectional analysis.

Authors:  Adam Sadowski; Ryan S Wexler; Douglas Hanes; Lita Buttolph; Tediana Torrens; Jillian Moehle; Hadil Sarrar; Joanna Harnett; David T Zava; Ryan Bradley
Journal:  BMC Complement Med Ther       Date:  2022-05-05

Review 3.  Pathophysiology of Mild Hypercortisolism: From the Bench to the Bedside.

Authors:  Vittoria Favero; Arianna Cremaschi; Chiara Parazzoli; Alberto Falchetti; Agostino Gaudio; Luigi Gennari; Alfredo Scillitani; Fabio Vescini; Valentina Morelli; Carmen Aresta; Iacopo Chiodini
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.